Solid-phase synthesis of a nonadecapeptide coded for by the v-myb oncogene

Area of Science:

• Oncogenic proteins
• Immunology
• Peptide synthesis

Background:

• The v-myb oncoprotein is implicated in various cancers.
• B-cell determinants are crucial for antibody recognition.
• Developing synthetic peptides for immunological studies is essential.

Purpose of the Study:

• To synthesize a nonadecapeptide representing a predicted B-cell determinant of the v-myb oncoprotein.
• To evaluate the immunogenicity of the synthesized peptide.

Main Methods:

• Solid-phase peptide synthesis (Merrifield method).
• Protective t-butyloxycarbonyl (Boc) group removal using hydrogen chloride in dichloromethane.
• Development and application of a new qualitative deprotection test.
• Coupling of the synthesized peptide to a carrier molecule.
• Immunization and antibody titer determination.

Main Results:

• Successful synthesis of the nonadecapeptide.
• Effective monitoring of deprotection using a novel qualitative test.
• The synthesized nonadecapeptide, when coupled to a carrier, induced a high titer of protein-reactive antipeptide antibodies.

Conclusions:

• The study demonstrates the feasibility of synthesizing a specific B-cell determinant peptide from v-myb.
• The synthetic peptide is immunogenic and elicits a strong antibody response.
• This work provides a foundation for developing v-myb-specific antibodies for research or therapeutic purposes.